Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Your plate after bariatric surgery: can it calm inflammation?

NCT ID NCT07293624

Knowledge-focused Sponsor: Istanbul Bilgi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study looks at how the foods people eat after bariatric surgery relate to inflammation in the body and stomach problems like bloating and gas. Researchers will collect diet records, blood samples, and symptom reports from 70 adults who had surgery at least 3 months ago. The goal is to see if a diet that causes more inflammation is linked to higher levels of inflammatory markers and worse digestive symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Aktif International Uskudar Hospital, Istanbul, Türkiye.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult individuals between the ages of 18 and 65, * Having undergone bariatric surgery at least 3 months prior, * Individuals who agreed to participate voluntarily in the study and signed the informed consent form, * Having the cognitive ability/literacy to completely complete the food consumption record and questionnaire forms, * Individuals with no health conditions that would prevent blood tests, * Individuals who were regularly followed up after surgery and had no postoperative complications. Exclusion Criteria: * Individuals diagnosed with gastrointestinal diseases such as inflammatory bowel disease, celiac disease, or short bowel syndrome before or after bariatric surgery, * Those with a history of diseases that could affect systemic inflammation, such as autoimmune disease, active infection, or cancer, * Individuals regularly taking medications that could affect inflammation levels, such as corticosteroids, immunosuppressants, or anti-inflammatory drugs, * Individuals actively or recently using probiotic supplements, * Pregnant or breastfeeding women, * Those with a history of chronic alcohol use or substance abuse, * Individuals who experienced serious postoperative complications after surgery (e.g., anastomotic leak, serious infection, or conditions requiring reoperation), * Individuals with cognitive or communication disabilities that prevented them from providing the necessary information and data to the study or who were lost to follow-up, * Individuals with chronic organ failure, * Individuals with a psychiatric diagnosis, * Individuals who did not consent to their data being used for scientific purposes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bariatric sleeve gastrectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bariatric sleeve gastrectomy Bariatric surgery Dietary inflammatory index (DII) Inflamation Systemic inflammation Systemic inflammation markers

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul Bilgi University

    Istanbul, Uskudar, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.